The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125562102 12556210 2 F 20160818 20160714 20160825 EXP CA-PFIZER INC-2015268970 PFIZER 51.00 YR F Y 0.00000 20160825 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125562102 12556210 1 PS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral 20 MG, WEEKLY N 11719 20 MG TABLET /wk
125562102 12556210 2 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral 15 MG, WEEKLY N 11719 15 MG TABLET /wk
125562102 12556210 3 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 25 MG, UNK N 11719 25 MG SOLUTION FOR INJECTION
125562102 12556210 4 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 25 UNK, UNK N 11719 25 MG SOLUTION FOR INJECTION
125562102 12556210 5 SS SULFASALAZINE. SULFASALAZINE 1 Oral 1 G, DAILY N 7073 1 G
125562102 12556210 6 SS PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 200 MG, 2X/DAY N 0 200 MG TABLET BID
125562102 12556210 7 SS PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 UNK N 0 TABLET
125562102 12556210 8 SS PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 200 MG, DAILY N 0 200 MG TABLET
125562102 12556210 9 C FOLIC ACID. FOLIC ACID 1 5 MG, WEEKLY 0 5 MG TABLET /wk
125562102 12556210 10 C NAPROSYN NAPROXEN 1 Oral 500 MG, 2X/DAY 0 500 MG BID
125562102 12556210 11 C TYLENOL WITH CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 UNK 0
125562102 12556210 12 C VIMOVO ESOMEPRAZOLE MAGNESIUMNAPROXEN 1 500/20 MG (1 TABLET) TWO TIMES DAILY 0 1 DF TABLET BID
125562102 12556210 13 C MELOXICAM. MELOXICAM 1 150 MG, DAILY 0 150 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125562102 12556210 1 Rheumatoid arthritis
125562102 12556210 3 Rheumatoid arthritis
125562102 12556210 6 Rheumatoid arthritis
125562102 12556210 12 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
125562102 12556210 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125562102 12556210 Axillary mass
125562102 12556210 Condition aggravated
125562102 12556210 Drug hypersensitivity
125562102 12556210 Drug intolerance
125562102 12556210 Dry mouth
125562102 12556210 Interstitial lung disease
125562102 12556210 Ocular hyperaemia
125562102 12556210 Photophobia
125562102 12556210 Rash
125562102 12556210 Rash pruritic
125562102 12556210 Rheumatoid arthritis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125562102 12556210 1 200710 2008 0
125562102 12556210 3 20080314 200806 0
125562102 12556210 4 2014 0
125562102 12556210 5 20071221 20080211 0
125562102 12556210 6 200711 200804 0
125562102 12556210 7 201409 0